Evidence map›Paper›PMID 24381187›Full record

Trial reportRespiratory care2014

The association between physiologic dead-space fraction and mortality in subjects with ARDS enrolled in a prospective multi-center clinical trial.

Richard H Kallet, Hanjing Zhuo, Kathleen D Liu, Carolyn S Calfee, Michael A Matthay, National Heart Lung and Blood Institute ARDS Network Investigators

Open access · bronzeAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Respiratory care, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 97 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Nasal high flow reduces dead space.Journal of applied physiology (Bethesda, Md. : 1985) · 2017
    Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Observational
  13. Review
  14. Article
  15. Observational
  16. Observational
  17. Article
  18. Article
  19. Monitoring Expired COFrontiers in physiology · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Richard H KalletRespiratory Care Services, University of California San Francisco Department of Anesthesia at San Francisco General Hospital.
Hanjing ZhuoCardiovascular Research Institute, University of California, San Francisco.
Kathleen D LiuDepartment of Nephrology, University of California, San Francisco.
Carolyn S CalfeeDepartment of Pulmonary and Critical Care Medicine, University of California, San Francisco, San Francisco, California.
Michael A MatthayCardiovascular Research Institute, University of California, San Francisco.
National Heart Lung and Blood Institute ARDS Network Investigators
University of California, San Francisco · USSan Francisco General Hospital · US

Funding

Resolution of Clinical Lung InjuryR37HL051856 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MATTHAY, MICHAEL A. · 2006 to 2015
$3.9M
NHLBI NIH HHS N01 HR056165NHLBI NIH HHS N01-HR-56165-56713NHLBI NIH HHS R37 HL051856
6 · The paper itself

Abstract

backgroundWe tested the association between pulmonary dead-space fraction (ratio of dead space to tidal volume [V(D)/V(T)]) and mortality in subjects with ARDS (Berlin definition, P(aO2)/F(IO2) ≤ 300 mm Hg; PEEP ≥ 5 cm H2O) enrolled into a clinical trial incorporating lung-protective ventilation.

methodsWe conducted a prospective, multi-center study at medical-surgical ICUs in the United States. A total of 126 ALI subjects with acute lung injury were enrolled into a phase 3 randomized, placebo-controlled study of aerosolized albuterol. V(D)/V(T) and pulmonary mechanics were measured within 4 h of enrollment and repeated daily on study days 1 and 2 in subjects requiring arterial blood gases for clinical management.

resultsAt baseline, non-survivors had a trend toward higher V(D)/V(T) compared with survivors (0.62 ± 0.11 vs 0.56 ± 0.11, respectively, P = .08). Differences in V(D)/V(T) between non-survivors and survivors became significant on study days 1 (0.64 ± 0.12 vs 0.55 ± 0.11, respectively, P = .01) and 2 (0.67 ± 0.12 vs 0.56 ± 0.11, respectively, P = .004). Likewise, the association between VD/VT and mortality was significant on study day 1 (odds ratio per 0.10 change in V(D)/V(T) [95% CI]: 6.84 [1.62-28.84] P = .01; and study day 2: 4.90 [1.28-18.73] P = .02) after adjusting for V(D)/V(T), P(aO2)/F(IO2), oxygenation index, vasopressor use, and the primary risk for ARDS. Using a Cox proportional hazard model, V(D)/V(T) was associated with a trend toward higher mortality (HR = 4.37 [CI 0.99-19.32], P = .052) that became significant when the analysis was adjusted for daily oxygenation index (HR = 1.74 [95% CI 1.12-3.35] P = .04).

conclusionsMarkedly elevated V(D)/V(T) (≥ 0.60) in early ARDS is associated with higher mortality. Measuring V(D)/V(T) may be useful in identifying ARDS patients at increased risk of death who are enrolled into a therapeutic trial.

Indexed as

FemaleFollow-Up StudiesHumansIntensive Care UnitsMaleMiddle AgedPositive-Pressure RespirationProspective StudiesRespiratory Distress SyndromeSurvival RateTidal VolumeUnited Statesacute lung injuryacute respiratory distress syndromemechanical ventilationphysiologic dead-space fractionsingle-breath test for carbon dioxide

Identifiers

PMID24381187
PMCPMC4077995
OpenAlexW2145613376

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.